| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10910817 | Lung Cancer | 2015 | 6 Pages |
Abstract
Sequential treatment with a 2nd ALK-TKI is effective in patients who fail a 1st ALK-TKI. Continuous ALK-inhibition upon failing a 1st ALK-TKI may be associated with improved clinical outcome.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Rita Chiari, Giulio Metro, Daniela Iacono, Guido Bellezza, Alberto Rebonato, Alessandra Dubini, Isabella Sperduti, Chiara Bennati, Luca Paglialunga, Marco Angelo Burgio, Sara Baglivo, Raffaele Giusti, Vincenzo Minotti, Angelo Delmonte, Lucio Crinò,